Puma Biotechnology's total assets for Q1 2025 were $196.18M, a decrease of -8.04% from the previous quarter. PBYI total liabilities were $99.07M for the fiscal quarter, a -18.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.